281 related articles for article (PubMed ID: 34016786)
1. Integrated bioinformatic analysis reveals the underlying molecular mechanism of and potential drugs for pulmonary arterial hypertension.
Dong H; Li X; Cai M; Zhang C; Mao W; Wang Y; Xu Q; Chen M; Wang L; Huang X
Aging (Albany NY); 2021 May; 13(10):14234-14257. PubMed ID: 34016786
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel biomarkers involved in pulmonary arterial hypertension based on multiple-microarray analysis.
Ma Y; Chen SS; Feng YY; Wang HL
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32886110
[TBL] [Abstract][Full Text] [Related]
3. Screening of key biomarkers and immune infiltration in Pulmonary Arterial Hypertension via integrated bioinformatics analysis.
Zeng Y; Li N; Zheng Z; Chen R; Liu W; Cheng J; Zhu J; Zeng M; Peng M; Hong C
Bioengineered; 2021 Dec; 12(1):2576-2591. PubMed ID: 34233597
[TBL] [Abstract][Full Text] [Related]
4. Screening of Hub Genes Associated with Pulmonary Arterial Hypertension by Integrated Bioinformatic Analysis.
Zeng Y; Li N; Zheng Z; Chen R; Peng M; Liu W; Zhu J; Zeng M; Cheng J; Hong C
Biomed Res Int; 2021; 2021():6626094. PubMed ID: 33816621
[TBL] [Abstract][Full Text] [Related]
5. Integrative analyses of gene expression profile reveal potential crucial roles of mitotic cell cycle and microtubule cytoskeleton in pulmonary artery hypertension.
Luo J; Li H; Liu Z; Li C; Wang R; Fang J; Lu S; Guo J; Zhu X; Wang X
BMC Med Genomics; 2020 Jun; 13(1):86. PubMed ID: 32586319
[TBL] [Abstract][Full Text] [Related]
6. Identification of hub genes based on integrated analysis of single-cell and microarray transcriptome in patients with pulmonary arterial hypertension.
Qin Y; Yan G; Qiao Y; Wang D; Tang C
BMC Genomics; 2023 Dec; 24(1):788. PubMed ID: 38110868
[TBL] [Abstract][Full Text] [Related]
7. Integrated Bioinformatics Analysis Reveals Marker Genes and Potential Therapeutic Targets for Pulmonary Arterial Hypertension.
Li A; He J; Zhang Z; Jiang S; Gao Y; Pan Y; Wang H; Zhuang L
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573320
[TBL] [Abstract][Full Text] [Related]
8. The identification and verification of hub genes associated with pulmonary arterial hypertension using weighted gene co-expression network analysis.
Wu W; Chen A; Lin S; Wang Q; Lian G; Luo L; Xie L
BMC Pulm Med; 2022 Dec; 22(1):474. PubMed ID: 36514015
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics analysis of the immune cell infiltration characteristics and correlation with crucial diagnostic markers in pulmonary arterial hypertension.
Lian G; You J; Lin W; Gao G; Xu C; Wang H; Luo L
BMC Pulm Med; 2023 Aug; 23(1):300. PubMed ID: 37582718
[TBL] [Abstract][Full Text] [Related]
10. Identification of Signal Pathways and Hub Genes of Pulmonary Arterial Hypertension by Bioinformatic Analysis.
Wei RQ; Zhang WM; Liang Z; Piao C; Zhu G
Can Respir J; 2022; 2022():1394088. PubMed ID: 36072642
[TBL] [Abstract][Full Text] [Related]
11. Integrated bioinformatics analysis reveals marker genes and immune infiltration for pulmonary arterial hypertension.
Tang S; Liu Y; Liu B
Sci Rep; 2022 Jun; 12(1):10154. PubMed ID: 35710932
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1 signaling pathway.
Liu P; Gu Y; Luo J; Ye P; Zheng Y; Yu W; Chen S
Exp Cell Res; 2019 Jul; 380(1):36-46. PubMed ID: 30802452
[TBL] [Abstract][Full Text] [Related]
13. Identifying Potential Mitochondrial Proteome Signatures Associated with the Pathogenesis of Pulmonary Arterial Hypertension in the Rat Model.
Wang J; Uddin MN; Li Q; Aierken A; Li MY; Wang R; Yan QZ; Adi D; Gai MT; Wu Y
Oxid Med Cell Longev; 2022; 2022():8401924. PubMed ID: 35237384
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin S promotes the development of pulmonary arterial hypertension.
Chang CJ; Hsu HC; Ho WJ; Chang GJ; Pang JS; Chen WJ; Huang CC; Lai YJ
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L1-L13. PubMed ID: 31017016
[TBL] [Abstract][Full Text] [Related]
15. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
[TBL] [Abstract][Full Text] [Related]
16. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
17. Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension.
Lin W; Tang Y; Zhang M; Liang B; Wang M; Zha L; Yu Z
Front Med (Lausanne); 2022; 9():894584. PubMed ID: 35646965
[TBL] [Abstract][Full Text] [Related]
18. NCAPG Promotes Pulmonary Artery Smooth Muscle Cell Proliferation as a Promising Therapeutic Target of Idiopathic Pulmonary Hypertension: Bioinformatics Analysis and Experiment Verification.
Fu B; Li Y; Shi X; Liu P; Zhang Y; Tian H
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233060
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatic Exploration of Hub Genes and Potential Therapeutic Drugs for Endothelial Dysfunction in Hypoxic Pulmonary Hypertension.
Chen A; Wu W; Lin S; Xie L
Comput Math Methods Med; 2022; 2022():3677532. PubMed ID: 36483920
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatic analysis and validation of microRNA-508-3p as a protective predictor by targeting NR4A3/MEK axis in pulmonary arterial hypertension.
Ma Y; Chen SS; Jiang F; Ma RY; Wang HL
J Cell Mol Med; 2021 Jun; 25(11):5202-5219. PubMed ID: 33942991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
